Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,632 total articles
The Elmet Group Co., a NASDAQ-listed U.S. provider of critical materials including tungsten, announced a $450 million committed investment from the U.S. Department of War to enhance domestic tungsten production and processing capabilities. The investment aims to reduce foreign dependence, expand manufacturing facilities in Maine, Michigan, and Ohio…
BioNTech, in collaboration with OncoC4, announced updated Phase 3 trial data showing that their investigational immunotherapy gotistobart significantly improves median overall survival to 18.5 months versus 10.0 months with standard chemotherapy in patients with previously treated squamous non-small cell lung cancer. The therapy's novel mechanism s…
Cellectis announces a strategic transformation to become an in vivo gene editing company, advancing two lead gene editing programs, .HEAL-101 and .HEAL-201, targeting severe hypertriglyceridemia and severe hypercholesterolemia respectively. The company plans to initiate Phase 1 trials and share preliminary data by 2027-2028, while exiting developme…
STMicroelectronics announced the introduction of its ST SafeSense VD56GA, a 1.1 MP automotive image sensor aimed at scaling affordable in-cabin sensing for driver and occupant monitoring. The sensor offers 35% higher image sharpness and nearly 60% greater infrared sensitivity compared to the previous generation, within a compact package that reduce…
Nanobiotix announced complete safety and efficacy results from the Phase 1 trial evaluating JNJ-1900 (NBTXR3), a radiotherapy-activated nanoparticle, in 24 patients with inoperable, recurrent non-small cell lung cancer. The trial showed no dose-limiting toxicities and clinically meaningful local tumor control at lower re-irradiation doses, with a o…
Baker Hughes has been awarded major contracts by Venture Global LNG to provide gas compression systems for the Cloud Connector Pipeline in Louisiana and modular liquefaction solutions to expand the Plaquemines LNG facility. These orders highlight the expansion of critical U.S. natural gas infrastructure supporting increased LNG supply and global en…
Axe Compute Inc. announced a non-qualified stock option grant of 60,000 shares at $10.67 per share to a new non-executive employee under Nasdaq Listing Rule 5635(c)(4). The option, granted outside the company's equity incentive plan, vests over three years and has a 10-year term. Axe Compute is a neocloud AI infrastructure provider based in Pittsbu…
EverCommerce Inc. announced that its Board of Directors has approved a $25 million increase to its existing $300 million share repurchase program, raising the total authorization to $325 million, extending the buyback program through December 31, 2027. The company plans to fund repurchases with cash on hand and may repurchase shares through open ma…
Grupo Aeroportuario del Pacífico (PAC) announced the execution of credit facilities amounting to Ps. 8,000 million with major banks including Santander, BBVA, HSBC, J.P. Morgan, and Scotiabank. The funds will be used primarily to repay maturing long-term debt certificates in September and October 2026, and to finance capital expenditures as part of…
ArrowMark Financial Corp., a Nasdaq-listed closed-end management investment company, announced a special cash distribution of $0.10 per share along with the regular monthly cash distribution of $0.15 per share for September 2026. The distributions underscore the company's ability to consistently exceed its declared quarterly distribution rate, emph…
Eastern International Ltd. (NASDAQ: ELOG) announced it received a Nasdaq notification for failing to meet the minimum bid price requirement of $1.00 per share for 30 consecutive trading days. The company now has 180 calendar days to regain compliance with this requirement or risk eventual delisting. Management will monitor the stock price and consi…
Biodexa Pharmaceuticals PLC announced its unaudited interim results for the six months ended June 30, 2026. Key developments include the in-license of MTX240 from Otsuka, expansion of its Phase 3 trial for eRapa in Familial Adenomatous Polyposis (FAP), Health Canada approval for trial expansion, and a post-period $3.5 million fundraise. R&D costs i…
Cellectis, a clinical-stage biotech company specializing in gene-editing CAR T immunotherapies, will hold a conference call and webcast on September 14, 2026, to provide a business update. The event will cover progress in its oncology and gene therapy programs using off-the-shelf allogeneic CAR T-cells.
AMREP Corporation reported a sharp decline in net income and revenues for the first quarter of fiscal 2027 compared to the same period in the prior year. Net income fell to $276,000 ($0.05 per diluted share) from $4.69 million ($0.87 per diluted share), while revenues dropped from $17.85 million to $6.05 million. The company noted that results can …
Standard Lithium Ltd. announced the resignation of board member Karen Narwold due to new executive commitments. The company is searching for a new independent director to complement its existing board and support its growth and strategic goals. Standard Lithium is focused on developing high-grade lithium-brine projects in the U.S., including partne…
Arteris, Inc. announced inducement equity awards granted to its new CFO, Saurabh Sinha. The awards include restricted stock units valued at $3.7 million and performance stock units valued at $1 million, with vesting linked to continued employment and specific revenue and share price targets. The grants aim to incentivize senior management alignment…
Rainier Acquisition Corporation announced that starting September 14, 2026, holders of its units can elect to separately trade Class A ordinary shares and warrants on Nasdaq. The units include one Class A share and one-quarter of a redeemable warrant. Separate trading for Class A shares and warrants will begin on September 15, 2026, under ticker sy…
Star Bulk Carriers Corp. completed a public offering of 4,400,000 new common shares priced at €24.50 (US$28.40) each, leading to a total demand over six times the shares issued, signaling strong investor interest. The shares will be listed on the Euronext Athens market alongside existing listings, with the offering restricted to non-U.S. persons un…
Kite Realty Group, a publicly traded real estate investment trust focused on open-air shopping centers and mixed-use destinations primarily in the Sun Belt and gateway markets, announced it will present at the upcoming BofA Securities 2026 Global Real Estate Conference. The presentation will provide updates on the company's business and investment …
CEA Industries Inc. reported a net loss of $11.4 million for Q1 fiscal 2027, driven by $15.3 million unrealized loss on digital assets primarily BNB tokens. The company holds over 515,000 BNB tokens valued at approximately $302 million, representing the largest corporate BNB treasury. Operational revenue declined slightly due to product discontinua…
Agomab Therapeutics NV announced that shareholders approved key resolutions including the appointment of Marino Garcia and Dr. Naimish Patel as non-executive board members. These appointments are expected to enhance the Company's strategic direction and oversight as it advances its clinical-stage pipeline targeting fibro-inflammatory diseases. Addi…
Impact BioMedical Inc. declared a 1-for-12.62 reverse stock split effective September 23, 2026, aimed at supporting its proposed merger with pharmaceutical company Zoar Ltd and maintaining NYSE American listing standards. The merger will create a combined company with expertise in manufacturing and clinical development of active pharmaceutical ingr…
Corbus Pharmaceuticals Holdings, a clinical-stage biotech company focusing on oncology and obesity treatments, announced a conference call scheduled for September 14, 2026, to discuss topline data from its CANYON-1 Phase 1b trial evaluating CRB-913, an oral CB1 inverse agonist aimed at treating obesity. The trial involved 240 obese, non-diabetic ad…
Gran Tierra Energy Inc. announced a consent solicitation to amend terms of its 9.75% Senior Secured Amortizing Notes due 2031 to facilitate a sale of its Swiss subsidiary Gran Tierra Energy CI GmbH to Maurel & Prom S.A. The amendments include collateral release and updates to accounting definitions, aiming to allow the purchaser to assume debt obli…
HII has been awarded a $336 million contract by the U.S. Navy to begin procurement of critical propulsion materials for the construction of the next-generation nuclear-powered aircraft carrier CVN 82 at its Newport News Shipbuilding division. This contract marks a significant step in the U.S. Navy's aircraft carrier program and signals robust deman…
